Sign in

Abstract

We assessed the impact of plasma protein quantitative trait loci (pQTL) on genetically supported therapeutic hypotheses. We show that pQTL-supported target-indication pairs were 4.4 times more likely to advance from Phase I to launch, compared to a 2.6-fold increase observed with other human genetic evidence. Moreover, pQTL-based enrichment was prominent in druggable protein families which had limited enrichment from other genetic evidence sources.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.